One study validated BCMA expression in DLBCL, FL, MCL, and CLL, and demonstrated that BCMA CAR T cells eradicated B-NHL cells in vitro and in vivo through target cell lysis24. The gene discussed is TNFRSF17; the disease is B-cell chronic lymphocytic leukemia.